Literature DB >> 24176574

Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines.

Jeremy Lewin1, Ajay Puri, Richard Quek, Roger Ngan, Ana Patricia Alcasabas, David Wood, David Thomas.   

Abstract

Sarcomas are a rare and diverse set of cancers that disproportionately affect young people. The best possible outcome depends on access to highly specialised, multidisciplinary care. Although advances have been made in therapeutic techniques, access to some treatments might be limited by cost implications. This Review proposes an evidence-based, consensus recommendation for optimum management of bone and soft-tissue sarcoma across the Asia-Pacific region, taking into account variation in health-care resources, stratified according to the Breast Health Global Initiative resource levels. A web-based survey of 89 clinicians involved in the care of patients with sarcoma from 18 Asia-Pacific countries generated the recommendations for diagnosis, staging, and management, including supportive and palliative care, and research.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24176574     DOI: 10.1016/S1470-2045(13)70475-3

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN: 1470-2045            Impact factor:   41.316


  12 in total

1.  Antitumor activity of yulangsan polysacchrides in mice bearing S180 sarcoma tumors.

Authors:  Wen'E Cai; Xiaoyu Chen; Qingdong Pan; Shijun Zhang; Luojiao Tan; Xuyong Sun; Renbin Huang; Aijun Xia
Journal:  Mol Clin Oncol       Date:  2017-08-16

Review 2.  Management of musculoskeletal tumours of the extremity in low-resource settings.

Authors:  Nicolas de l'Escalopier; Laurent Mathieu; Philippe Anract; David Biau
Journal:  Int Orthop       Date:  2021-09-07       Impact factor: 3.075

Review 3.  Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Authors:  Carlos Rodriguez-Galindo; Paola Friedrich; Patricia Alcasabas; Federico Antillon; Shripad Banavali; Luis Castillo; Trijn Israels; Sima Jeha; Mhammed Harif; Michael J Sullivan; Thuan Chong Quah; Catherine Patte; Ching-Hon Pui; Ronald Barr; Thomas Gross
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

4.  Wiki-based clinical practice guidelines for the management of adult onset sarcoma: a new paradigm in sarcoma evidence.

Authors:  S J Neuhaus; D Thomas; J Desai; C Vuletich; J von Dincklage; I Olver
Journal:  Sarcoma       Date:  2015-02-16

5.  Rare chondrosarcoma of the breast treated with quadrantectomy instead of mastectomy: A case report.

Authors:  Vittorio Pasta; Daniela Sottile; Paolo Urciuoli; Luca Del Vecchio; Filippo Custureri; Valerio D'Orazi
Journal:  Oncol Lett       Date:  2014-12-17       Impact factor: 2.967

6.  A phase Ib/II translational study of sunitinib with neoadjuvant radiotherapy in soft-tissue sarcoma.

Authors:  J Lewin; K K Khamly; R J Young; C Mitchell; R J Hicks; G C Toner; S Y K Ngan; S Chander; G J Powell; A Herschtal; L Te Marvelde; J Desai; P F M Choong; S A Stacker; M G Achen; N Ferris; S Fox; J Slavin; D M Thomas
Journal:  Br J Cancer       Date:  2014-10-16       Impact factor: 7.640

Review 7.  Orthopedic oncology - "the challenges ahead".

Authors:  Ajay Puri
Journal:  Front Surg       Date:  2014-07-21

8.  Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians.

Authors:  Jeremy Lewin; Kate Thompson; Susie Bae; Jayesh Desai; Robyn Strong; Denise Caruso; Deborah Howell; Alan Herschtal; Michael Sullivan; Lisa Orme
Journal:  Sarcoma       Date:  2017-02-28

Review 9.  Anlotinib: a novel multi-targeting tyrosine kinase inhibitor in clinical development.

Authors:  Guoshuang Shen; Fangchao Zheng; Dengfeng Ren; Feng Du; Qiuxia Dong; Ziyi Wang; Fuxing Zhao; Raees Ahmad; Jiuda Zhao
Journal:  J Hematol Oncol       Date:  2018-09-19       Impact factor: 17.388

10.  Survival-associated alternative splicing signatures in soft tissue sarcomas.

Authors:  Xianghai Ren; Qi Jiang; Long Li
Journal:  Ann Transl Med       Date:  2020-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.